NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹273 Cr | ₹363 Cr | ₹165 Cr | ₹404 Cr | ₹266 Cr |
What is the latest Total Debt ratio of NATCO PHARMA ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹273 Cr |
| Mar2024 | ₹363 Cr |
| Mar2023 | ₹165 Cr |
| Mar2022 | ₹404 Cr |
| Mar2021 | ₹266 Cr |
How is Total Debt of NATCO PHARMA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹273 Cr | -24.81 | |
| Mar2024 | ₹363 Cr | 120.12 | |
| Mar2023 | ₹165 Cr | -59.16 | |
| Mar2022 | ₹404 Cr | 51.99 | |
| Mar2021 | ₹266 Cr | - | |
Compare Total Debt of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹19,565.8 Cr | -0.6% | 14.1% | 29.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹388,680.0 Cr | -2.9% | -8.9% | -3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,817.0 Cr | 1.2% | 4.2% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,297.0 Cr | -1.7% | -3.6% | 27.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,828.0 Cr | 6.8% | 1.3% | 13.2% | Stock Analytics | |
| CIPLA | ₹104,588.0 Cr | 5.4% | 3.1% | -13.6% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -0.6% |
14.1% |
29.2% |
| SENSEX | -2.3% |
3.3% |
-2.4% |
You may also like the below Video Courses